A carregar...
Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance
OBJECTIVE: Metformin is used to treat type 2 diabetes. We sought to determine whether metformin reduces inflammation, by regulating p-signal transducer and activator of transcription 3 (STAT3) expression and T-helper 17 (Th17) cell proliferation, in a mouse model of inflammatory bowel disease (IBD)....
Na minha lista:
Publicado no: | PLoS One |
---|---|
Main Authors: | , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Public Library of Science
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4567351/ https://ncbi.nlm.nih.gov/pubmed/26360050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0135858 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|